120 results
Page 6 of 6
6-K
EX-99.1
umf4m3v
18 Dec 18
Current report (foreign)
6:07am
6-K
EX-99.1
8zif2bp2gsc3
1 Nov 18
Current report (foreign)
10:06am
6-K
EX-99.2
lfwfitfc6sepitr4hg1x
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
6-K
EX-99.1
ah37db5w px
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
424B5
yqkpmu
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
k0ki6rnhd08icn3 g4
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
xtx224o e60yvwyo1mp
9 Jul 18
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
6:10am
6-K
EX-99.1
y0vq2
29 Jun 18
Topline results of PELICAN trial and update on triple combo development plans
12:00am
6-K
EX-99.1
czs 6p6gpnp4j9hhnz
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
6-K
EX-99.2
kvsb d3ww0ni5m5cp9
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-99.1
rhj2r dio2kl0w5109v
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
424B5
xa05ug
18 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
ei0nb0hcwz7soe1xa md
17 Apr 17
Prospectus supplement for primary offering
12:00am
20-F
n4jnyu
25 Mar 16
Annual report (foreign)
12:00am
DRS/A
EX-10
k08kj24u1fy2e 807
4 Mar 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10
r7u y0bsekh1n7mt
4 Mar 15
Draft registration statement (amended)
12:00am
DRS
ihjuwql kkx9qsp8pug
6 Feb 15
Draft registration statement
12:00am